Proton pump inhibitors and the risk of pancreatic cancer
- PMID: 33527212
- DOI: 10.1007/s00535-021-01761-8
Proton pump inhibitors and the risk of pancreatic cancer
Comment on
-
Proton pump inhibitors and the risk of pancreatic cancer.J Gastroenterol. 2021 Mar;56(3):293-294. doi: 10.1007/s00535-021-01764-5. Epub 2021 Feb 5. J Gastroenterol. 2021. PMID: 33544263 No abstract available.
References
-
- Brusselaers N, Sadr-Azodi O, Engstrand L. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. J Gastroenterol. 2020;55:453–61. - DOI
-
- Lai S-W. Proton pump inhibitors and the risk of pancreatic cancer. Journal of gastroenterology. 2021:In press.
-
- Pottegård A, Broe A, Hallas J, et al. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9:671–8. - DOI
-
- Brusselaers N, Wahlin K, Engstrand L, et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. 2017;7:e017739. - DOI
-
- Matuz M, Benkő R, Engi Z, et al. Use of proton pump inhibitors in Hungary: mixed-method study to reveal scale and characteristics. Front Pharmacol. 2020;11:552102. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
